Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epithelioid Sarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07734116
What this trial is testing

ONO-4538HSC in Pediatric Patients With Malignant Solid Tumors and in Patients With Epithelioid Sarcoma.

Who this might be right for
Pediatric Malignant Solid Tumor and Epithelioid Sarcoma
Ono Pharmaceutical Co., Ltd. 50
Testing effectiveness (Phase 2)Study completedNCT00003939
What this trial is testing

Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma

Who this might be right for
Brain and Central Nervous System TumorsEndometrial CancerGastrointestinal Stromal Tumor+3 more
European Organisation for Research and Treatment of Cancer - EORTC 132
Not applicableStudy completedNCT04008238
What this trial is testing

Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients

Who this might be right for
Soft Tissue Sarcoma AdultUndifferentiated Pleomorphic SarcomaEpithelioid Sarcoma+4 more
Institut Bergonié 29
Not applicableLooking for participantsNCT06715579
What this trial is testing

Cardiac Angiosarcoma International Registry

Who this might be right for
Cardiac Angiosarcoma
Immune Oncology Research Institute 500
Early research (Phase 1)Study completedNCT04537715
What this trial is testing

Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels

Who this might be right for
All MalignanciesAdvanced MalignanciesHematologic Malignancy+9 more
Epizyme, Inc. 42
Not applicableUnknownNCT00900211
What this trial is testing

Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEX

Who this might be right for
Sarcoma
The Christie NHS Foundation Trust 400
Testing effectiveness (Phase 2)Study completedNCT02815995
What this trial is testing

Multi-Arm Study to Test the Efficacy of Immunotherapeutic Agents in Multiple Sarcoma Subtypes

Who this might be right for
Advanced and/or Metastatic Sarcoma
M.D. Anderson Cancer Center 57
Testing effectiveness (Phase 2)Looking for participantsNCT04390737
What this trial is testing

Evaluate the Safety and Clinical Activity of HH2853

Who this might be right for
FL LymphomaEpithelioid SarcomaPeripheral T Cell Lymphoma+1 more
Haihe Biopharma Co., Ltd. 254
Early research (Phase 1)Study completedNCT00030784
What this trial is testing

Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 28
Testing effectiveness (Phase 2)Looking for participantsNCT06277154
What this trial is testing

MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma

Who this might be right for
LeiomyosarcomaLiposarcomaSynovial Sarcoma+8 more
HRYZ Biotech Co. 148
Testing effectiveness (Phase 2)Study completedNCT00025441
What this trial is testing

Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors

Who this might be right for
Ovarian CancerSarcomaSmall Intestine Cancer
Societe Internationale d'Oncologie Pediatrique
Testing effectiveness (Phase 2)UnknownNCT00410462
What this trial is testing

Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma

Who this might be right for
Ovarian CancerSarcomaSmall Intestine Cancer
European Organisation for Research and Treatment of Cancer - EORTC 118
Testing effectiveness (Phase 2)Ended earlyNCT00740597
What this trial is testing

Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma

Who this might be right for
Sarcoma
City of Hope Medical Center 1
Not applicableStudy completedNCT03837678
What this trial is testing

Epithelioid Sarcoma Natural History Study

Who this might be right for
Epithelioid Sarcoma
Epizyme, Inc. 74
Testing effectiveness (Phase 2)Study completedNCT03277924
What this trial is testing

Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas

Who this might be right for
Soft Tissue SarcomaBone Sarcoma
Grupo Espanol de Investigacion en Sarcomas 197
Testing effectiveness (Phase 2)Looking for participantsNCT07467772
What this trial is testing

Ph 2 Elacestrant in ER Positive Uterine Sarcomas

Who this might be right for
Uterine SarcomaUterine LeiomyosarcomaEndometrial Stromal Sarcoma+6 more
Dana-Farber Cancer Institute 30
Early research (Phase 1)Ended earlyNCT01552434
What this trial is testing

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

Who this might be right for
Advanced Malignant NeoplasmCastleman DiseaseDigestive System Carcinoma+36 more
M.D. Anderson Cancer Center 154
Testing effectiveness (Phase 2)Study completedNCT00474994
What this trial is testing

Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas

Who this might be right for
Adult Malignant Fibrous Histiocytoma of BoneDesmoid TumorEndometrial Cancer+3 more
Memorial Sloan Kettering Cancer Center 53
Early research (Phase 1)Ended earlyNCT04965753
What this trial is testing

FHD-609 in Subjects With Advanced Synovial Sarcoma or Advanced SMARCB1-Loss Tumors

Who this might be right for
Advanced Synovial Sarcoma
Foghorn Therapeutics Inc. 55
Early research (Phase 1)Ended earlyNCT05355753
What this trial is testing

Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors

Who this might be right for
Synovial SarcomaSoft Tissue Sarcoma
C4 Therapeutics, Inc. 49
Next Page